Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

450 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP. Teunissen JJ, et al. Among authors: krenning ep. Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. doi: 10.1530/ERC-10-0282. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 22005114 Review.
Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon.
Kaloudi A, Nock BA, Lymperis E, Krenning EP, de Jong M, Maina T. Kaloudi A, et al. Among authors: krenning ep. Cancer Biother Radiopharm. 2016 Feb;31(1):20-8. doi: 10.1089/cbr.2015.1935. Cancer Biother Radiopharm. 2016. PMID: 26844849
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, Nock BA, de Jong M, Baum RP. Maina T, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2016 May;43(5):964-973. doi: 10.1007/s00259-015-3232-1. Epub 2015 Dec 2. Eur J Nucl Med Mol Imaging. 2016. PMID: 26631238
[DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.
Tatsi A, Maina T, Cescato R, Waser B, Krenning EP, de Jong M, Cordopatis P, Reubi JC, Nock BA. Tatsi A, et al. Among authors: krenning ep. Eur J Med Chem. 2014 Feb 12;73:30-7. doi: 10.1016/j.ejmech.2013.12.003. Epub 2013 Dec 16. Eur J Med Chem. 2014. PMID: 24378707
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer.
Bodei L, Kwekkeboom DJ, Kidd M, Modlin IM, Krenning EP. Bodei L, et al. Among authors: krenning ep. Semin Nucl Med. 2016 May;46(3):225-38. doi: 10.1053/j.semnuclmed.2015.12.003. Semin Nucl Med. 2016. PMID: 27067503 Review.
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors.
Kwekkeboom DJ, Krenning EP. Kwekkeboom DJ, et al. Among authors: krenning ep. Hematol Oncol Clin North Am. 2016 Feb;30(1):179-91. doi: 10.1016/j.hoc.2015.09.009. Hematol Oncol Clin North Am. 2016. PMID: 26614376 Review.
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience.
Delpassand ES, Samarghandi A, Zamanian S, Wolin EM, Hamiditabar M, Espenan GD, Erion JL, O'Dorisio TM, Kvols LK, Simon J, Wolfangel R, Camp A, Krenning EP, Mojtahedi A. Delpassand ES, et al. Among authors: krenning ep. Pancreas. 2014 May;43(4):518-25. doi: 10.1097/MPA.0000000000000113. Pancreas. 2014. PMID: 24632546 Clinical Trial.
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.
Bergsma H, van Vliet EI, Teunissen JJ, Kam BL, de Herder WW, Peeters RP, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: krenning ep. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):867-81. doi: 10.1016/j.bpg.2013.01.004. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582925
Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
Barone R, Pauwels S, De Camps J, Krenning EP, Kvols LK, Smith MC, Bouterfa H, Devuyst O, Jamar F. Barone R, et al. Among authors: krenning ep. Nephrol Dial Transplant. 2004 Sep;19(9):2275-81. doi: 10.1093/ndt/gfh362. Epub 2004 Jul 13. Nephrol Dial Transplant. 2004. PMID: 15252161
Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.
Capello A, Krenning EP, Bernard BF, Breeman WA, van Hagen MP, de Jong M. Capello A, et al. Among authors: krenning ep. J Nucl Med. 2004 Oct;45(10):1716-20. J Nucl Med. 2004. PMID: 15471839
450 results
Jump to page
Feedback